<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">myrwd</journal-id><journal-title-group><journal-title xml:lang="ru">Реальная клиническая практика: данные и доказательства</journal-title><trans-title-group xml:lang="en"><trans-title>Real-World Data &amp; Evidence</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2782-3784</issn><publisher><publisher-name>Publishing House OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2782-3784-myrwd-3</article-id><article-id custom-type="edn" pub-id-type="custom">NYUZGG</article-id><article-id custom-type="elpub" pub-id-type="custom">myrwd-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ РЕГИСТРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL REGISTERS</subject></subj-group></article-categories><title-group><article-title>Регистры как основа для сбора данных и построения доказательств</article-title><trans-title-group xml:lang="en"><trans-title>Registers as the basis for data collection and evidence building</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3487-928X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванов Александр Викторович – начальник отдела стратегического консалтинга </p><p>Москва</p></bio><bio xml:lang="en"><p>Alexander V. Ivanov – head of Strategic Consulting Department </p><p>Moscow</p></bio><email xlink:type="simple">a.ivanov@aston-health.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ЗАО «Астон Консалтинг»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>ZAO "Aston Consulting"</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>01</day><month>09</month><year>2021</year></pub-date><volume>1</volume><issue>1</issue><fpage>10</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Иванов А.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Иванов А.В.</copyright-holder><copyright-holder xml:lang="en">Ivanov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.myrwd.ru/jour/article/view/5">https://www.myrwd.ru/jour/article/view/5</self-uri><abstract><p>Развитие медицинской науки требует постоянного повышения эффективности и безопасности лечения. Одним из способов решения этих задач служит сбор данных реальной клинической практики (RWD). Клинические регистры – одна из важнейших составных частей этого процесса. Клинические регистры позволяют собирать данные о применении медицинских технологий и проводить мониторинг результатов терапии в условиях реальной клинической практики. Введение в широкую медицинскую практику регистров пациентов и сбор данных RWD может способствовать оптимизации расходов при лечении высокозатратных нозологий и более рациональному планированию бюджета.</p></abstract><trans-abstract xml:lang="en"><p>The development of medical science requires a constant increase in the effectiveness and safety of treatment. Collection of real-world data (RWD) is one way of solving these problems. Clinical registries are one of the most important parts of this process. Clinical registries allow collecting data on the use of medical technologies and monitoring the results of therapy in real clinical practice. The introduction of patient registers and the collection of RWD data into widespread medical practice can help to optimize costs in the treatment of high-cost diseases and to better plan the budget.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>медицинские регистры</kwd><kwd>лекарственный регистр</kwd><kwd>регистр нозологий</kwd><kwd>данные реальной клинической практики</kwd><kwd>RWD</kwd><kwd>RWE</kwd></kwd-group><kwd-group xml:lang="en"><kwd>medical registries</kwd><kwd>drug register</kwd><kwd>register of nosologies</kwd><kwd>real-world data</kwd><kwd>RWD</kwd><kwd>RWE</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions. Доступно по: https://www.fda.gov/science-research/science-and-research-specialtopics/real-world-evidence.</mixed-citation><mixed-citation xml:lang="en">Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in healthcare decisions. Available at https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Framework for FDA’s Real-World Evidence Program. Доступно по: https://www.fda.gov/media/120060/download.</mixed-citation><mixed-citation xml:lang="en">Framework for FDA’s Real-World Evidence Program. Available from https://www.fda.gov/media/120060/download.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">EMA.Patient registries. Доступно по: https://www.ema.europa.eu/en/human-regulatory/postauthorisation/patient-registries [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">EMA. Patient registries. Available at https://www.ema.europa.eu/en/human-regulatory/post-authorisation/patient-registries [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кобринский Б. А. Автоматизированные регистры медицинского назначения: теория и практика применения / Б. А.Кобринский. – М.: ИД «Менеджер здравоохранения», 2011. – 148 с.</mixed-citation><mixed-citation xml:lang="en">Kobrinsky BA Automated registers for medical purposes: theory and practice of application/BA Kobrinsky. - M.: Publishing House "Health manager", 2011. - 148 p.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный закон от 29.11.2010 № 326-ФЗ «Об обязательном медицинском страховании в Российской Федерации». Доступно по: http://www.kremlin.ru/acts/bank/32206 [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">Federal Law of November 29, 2010 No. 326-FZ "On Compulsory Medical Insurance in the Russian Federation." Available at http://www.kremlin.ru/acts/bank/32206 [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Железнякова И. А., Пирова Г. И., Прохорович Е. А. Регистры пациентов и реестры счетов по ОМС: вопросы интеграции и взаимозаменяемости. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2018;11(4):067–072. doi: 10.17749/2070-4909.2018.11.4.067-072</mixed-citation><mixed-citation xml:lang="en">Zheleznyakova IA, Pirova GI, Prokhorovich EA. Registers of patients and registers of accounts for compulsory medical insurance: issues of integration and interchangeability. Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2018; 11 (4): 067–072. doi: 10.17749/2070-4909.2018.11.4.067-072</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Поддубная И. В., Стефанов Д. Н. Раковые регистры: вчера, сегодня, завтра.Современная онкология. 2012;14(1):7–9.</mixed-citation><mixed-citation xml:lang="en">Poddubnaya IV, Stefanov DN. Cancer registers: yesterday, today, tomorrow. Modern oncology. 2012; 14 (1): 7–9.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения Российской Федерации от 19 апреля 1999 г. № 135 «О совершенствовании системы государственного ракового регистра». Доступно по: https://docs.cntd.ru/document/902136492 [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of the Russian Federation of April 19, 1999 No. 135 "On improving the system of the state cancer registry." Available at https://docs.cntd.ru/document/902136492 [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">https://aston-health.com/therapeutic-areas/endocrinology.html [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">https://aston-health.com/therapeutic-areas/endocrinology.html [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С. А., Марцевич С. Ю., Кутишенко Н. П., Дроздова Л. Ю., Лукьянов М. М., Загребельный А. В., Гинзбург М. Л. Регистры в кардиологии. Основные правила проведения и реальные возможности. Кардиоваскулярная терапия и профилактика. 2013:12(1):4–9.</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Martsevich S. Yu., Kutishenko NP, Drozdova L. Yu., Lukyanov MM, Zagrebelny AV, Ginzburg ML. Registers in cardiology. Basic rules and real opportunities. Cardiovascular therapy and prevention. 2013: 12 (1): 4–9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Van Vollenhoven R. F., Askling J. Rheumatoid arthritis registries in Sweden. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S195–200.</mixed-citation><mixed-citation xml:lang="en">Van Vollenhoven R. F., Askling J. Rheumatoid arthritis registries in Sweden. Clin Exp Rheumatol. 2005; 23 (5 Suppl 39): S195-200.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Asklin G. J. et al. Risk for lymphomas following TNFblockade. Comparison with a nationwide comorbidity database. Ann Rheum Dis. 2004;63(Suppl. 1):258.</mixed-citation><mixed-citation xml:lang="en">Asklin G. J. et al. Risk of lymphomas following TNF-blockade. Comparison with a nationwide comorbidity database. Ann Rheum Dis. 2004; 63 (Suppl. 1): 258.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Geborek P., Crnkic M., Petersson I. F., Saxne T., South Swedish Arthritis Treatment Group. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. Ann Rheum Dis. 2002;61(9):793–8. doi: 10.1136/ard.61.9.793</mixed-citation><mixed-citation xml:lang="en">Geborek P., Crnkic M., Petersson I. F., Saxne T., South Swedish Arthritis Treatment Group. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow-up program in southern Sweden. Ann Rheum Dis. 2002; 61 (9): 793–8. doi: 10.1136/ard.61.9.793</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kobelt G., Eberhardt K., Geborek P. TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden. AnnRheum Dis. 2004;63(1):4–10. doi: 10.1136/ard.2003.010629</mixed-citation><mixed-citation xml:lang="en">Kobelt G., Eberhardt K., Geborek P. TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow-up study of patients with RA treated with etanercept or infliximab in southern Sweden. Ann Rheum Dis. 2004; 63 (1): 4–10. doi: 10.1136/ard.2003.010629</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Loginova E., Korotaeva T., Koltakova A., et al. THU0305 Minimal disease activity (MDA) attainment after starting biological (B) DMARDS and non-BDMARDS treatment in psoriatic arthritis patients (PTS) in routine care: Russian psoriatic arthritis registry (RU-PSART) data. Ann Rheum Dis. 2018;77:370–1. Доступнопо: https://ard.bmj.com/content/annrheumdis/77/Suppl_2/370.3.full.pdf.doi: 10.1136/annrheumdis-2018-eular.2695</mixed-citation><mixed-citation xml:lang="en">Loginova E., Korotaeva T., Koltakova A., et al. THU0305. Minimal disease activity (MDA) attainment after starting biological (B) DMARDS and non-BDMARDS treatment in psoriatic arthritis patients (PTS) in routine care: Russian psoriatic arthritis registry (RU-PSART) data. Ann Rheum Dis. 2018; 77: 370–1. Available at https://ard.bmj.com/content/annrheumdis/77/Suppl_2/370.3.full.pdf. doi: 10.1136/annrheumdis-2018-eular.2695</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Приказ Министерства здравоохранения РФ № 404 от 10 декабря 1996 года (утратил силу). Доступно по: https://docs.cntd.ru/document/9036715 [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">The order of the Ministry of Health of the Russian Federation No. 404 of December 10, 1996 (invalidated). Available at https://docs.cntd.ru/document/9036715 [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова М. В., Викулова О. К., Железнякова А. В., Исаков М. А., Дедов И. И. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4–13. doi: 10.26442/00403660.2019.10.000364</mixed-citation><mixed-citation xml:lang="en">Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Dedov II Epidemiology of diabetes mellitus in the Russian Federation: what has changed over the past decade? Therapeutic archive. 2019; 91 (10): 4–13. doi: 10.26442/00403660.2019.10.000364</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Дроздова Л. Ю., Кутишенко Н. П., Гинзбург М. Л. Регистры как способ изучения эффективности и безопасности лекарственных препаратов. Клиницист. 2012;(3-4):4–9.</mixed-citation><mixed-citation xml:lang="en">Martsevich S. Yu., Drozdova L. Yu., Kutishenko NP, Ginzburg ML Registers as a way to study the effectiveness and safety of drugs. Clinicians. 2012; (3–4): 4–9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Исследования реальной клинической практики / А. С. Колбин, Д. Ю. Белоусов, С. К. Зырянов, В. В. Омельяновский, Д. А. Сычёв, А. Л. Хохлов, С. Л. Плавинский, Б. К. Романов, М. В. Журавлёва, Е. В. Вербицкая, Е. А. Вольская, Д. А. Рождественский, С. В. Глаголев, М. Ю. Фролов, А. В. Рудакова, А. В. Павлыш, Ю. Е. Балыкина, А. А. Курылёв, А. В. Иванов, Д. С. Козлов, С. Б. Васильченко, Т. И. Галимов, О. А. Логиновская, С. А. Мишинова, Т. А. Гольдина, В. А. Булатов, Е. В. Лаврентьева, В. В. Горин, Л. А. Худова, В. В. Секачёв, И. В. Ефименко, Л. И. Карпенко, А. А. Поликарова. – М. : Издательство ОКИ : Буки Веди, 2020. – 208 с. : ил. – ISBN 978-5-4465-2902-5. – Доступно по: https://clck.ru/QkeeP [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">Real-world clinical study / A. S. Kolbin, D. Yu. Belousov, S. K. Zyryanov, V. V. Omelyanovsky, D. A. Sychev, A. L. Khokhlov, S. L. Plavinsky, B K. Romanov, M. V. Zhuravleva, E. V. Verbitskaya, E. A. Volskaya, D. A. Rozhdestvensky, S. V. Glagolev, M. Yu. Frolov, A. V. Rudakova, A. V Pavlysh, Yu. E. Balykina, A. A. Kurylev, A. V. Ivanov, D. S. Kozlov, S. B. Vasilchenko, T. I. Galimov, O. A. Loginovskaya, S. A. Mishinova , T. A. Gol'dina, V. A. Bulatov, E. V. Lavrent'eva, V. V. Gorin, L. A. Khudova, V. V. Sekachev, I. V. Efimenko, L. I. Karpenko, A. A. Polikarova. - M.: Publishing house OKI: Buki Vedi, 2020.-- 208 p. : ill. - ISBN 978-5-4465-2902-5. - Available at https://clck.ru/QkeeP [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Registries for Evaluating Patient Outcomes:A User’s Guide. Доступно по: https://effectivehealthcare.ahrq.gov/products/registries-guide-4th-edition [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">Registries for Evaluating Patient Outcomes: A User's Guide. Available at https://effectivehealthcare.ahrq.gov/products/registries-guide-4th-edition [Internet] (date accessed: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный закон от 21.11.2011 № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации». Доступно по: https://minzdrav.gov.ru/documents/7025 [Internet] (дата обращения: 14.08.2021).</mixed-citation><mixed-citation xml:lang="en">Federal Law of 21.11.2011 No. 323-FZ "On the basics of protecting the health of citizens in the Russian Federation." Available at https://minzdrav.gov.ru/documents/7025 [Internet] (date of access: 14.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Защита персональных данных осуществляется в соответствии с Федеральным законом о персональных данных от 27.07.2006 № 152-ФЗ. Доступно по: http://www.kremlin.ru/acts/bank/24154/page/1[Internet] (дата обращения: 06.08.2021).</mixed-citation><mixed-citation xml:lang="en">The protection of personal data is performed in accordance with the Federal Law on Personal Data of 27.07.2006 No. 152-FZ. Available at http://www.kremlin.ru/acts/bank/24154/page/1 [Internet] (date accessed: 06.08.2021).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
